Italian aerosol device and filling machine company Coster Pharma has announced that its Type 3 Drug Master File (DMF) for two of its MDI valves to the FDA has been issued the DMF number 26960. Both of the 20mm valves are manufactured at the company’s clean room facility in Trento, Italy. The 20DR valve is available for 50, 65, 75, and 100 µl dosing, and the 20DPH valve is available for 25, 50, 63, and 100 µl dosing.
Coster announces US DMF number for MDI valves
published on
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA